Target intelligence / Profile preview

RPL37A divergent transcript (RPL37A-DT)

Target
RPL37A-DT
Molecular classification
Other, Long non-coding RNA, divergent transcript
01

Overview

RPL37A divergent transcript (RPL37A-DT) is a human long non-coding RNA (lncRNA) gene located near the coding gene RPL37A. It does not encode a protein and its biological function is not currently established. The locus has no known Mendelian phenotype association and is not reported as a receptor, enzyme, transporter, or other classical drug target. As a divergent transcript, it is classified as a non-coding RNA, and may have regulatory functions typical of lncRNAs, but specific roles in health or disease have not been characterized. RPL37A-DT must be distinguished from RPL37A, a protein-coding gene encoding a ribosomal protein, which does have known biological roles and disease associations. RPL37A-DT is confirmed as a distinct gene with the type "ncRNA (non-coding RNA)" in gene databases and has no known involvement as a primary target for therapeutics or as a disease biomarker. No common aliases or substantial functional/mechanistic information is currently available, reflecting the limited understanding of this lncRNA in biomedical literature.

Other names
RPL37A-DTRPL37A divergent transcript
02

Mechanism of action

Not applicable; no known drug interactions or therapeutic mechanism established

03

Biological functions

Currently unknown; long non-coding RNAs can be involved in gene regulation and epigenetic modulation, but no clear function for RPL37A-DT is established
04

Disease associations

No direct disease associations knownWas included in a methylation study of lncRNAs in cancer but not specifically highlighted as disease-associated

Beyond the preview

Go deeper on RPL37A divergent transcript (RPL37A-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RPL37A divergent transcript (RPL37A-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call